Report copyright - ENGINEERED CAR-T THERAPIES - Cellectis · Enhancing CAR T-Cell Capabilities Chemo-resistance § Gene editing to knock out CD52 or DCK on T-Cell surface in order to induce resistance
Please pass captcha verification before submit form